ArticleMolecular therapy. Oncology2025

Oncolytic herpes simplex virus reprograms cancer-associated fibroblasts to enhance antitumor immunity in pancreatic cancer.

Feilong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.